<?xml version="1.0" encoding="UTF-8" ?> 

<rss version="2.0"> 
<channel> 
<title>Gynecologic Oncology News</title> 
<link>http://www.mdlinx.com/HemeOncLinx/news.cfm/newspage/1/spec_id/17/subspec_id/399</link> 
<description>Gynecologic Oncology</description> 
<language>en-us</language> 
<copyright>Copyright 2009 MDLinx, Inc.</copyright>










 



<item> 
<title><![CDATA[A new multiparameter assay to assess HPV 16/18, viral load and physical status together with gain of telomerase genes in HPV-related cancers]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2942260</link> 
<pubDate>11/10/2009</pubDate> 
<description><![CDATA[<b>International Journal of Cancer</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2942260</guid>
</item> 
 

<item> 
<title><![CDATA[A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: Methodology and interim results after three rounds of screening]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2942264</link> 
<pubDate>11/10/2009</pubDate> 
<description><![CDATA[<b>International Journal of Cancer</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2942264</guid>
</item> 
 

<item> 
<title><![CDATA[STX140 and STX641 Cause Apoptosis via the Intrinsic Mitochondrial Pathway and Down-regulate Survivin and XIAP Expression in Ovarian and Prostate Cancer Cells]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2943819</link> 
<pubDate>11/10/2009</pubDate> 
<description><![CDATA[<b>Anticancer Research</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2943819</guid>
</item> 
 

<item> 
<title><![CDATA[Cisplatin and Oxaliplatin Cytotoxic Effects in Sensitive and Cisplatin-resistant Human Cervical Tumor Cells: Time and Mode of Application Dependency]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2943845</link> 
<pubDate>11/10/2009</pubDate> 
<description><![CDATA[<b>Anticancer Research</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2943845</guid>
</item> 


 

<item> 
<title><![CDATA[Potent Inhibition of Tubulin Polymerisation and Proliferation of Paclitaxel-resistant 1A9PTX22 Human Ovarian Cancer Cells by Albendazole]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2943824</link> 
<pubDate>11/10/2009</pubDate> 
<description><![CDATA[<b>Anticancer Research</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2943824</guid>
</item> 
 

<item> 
<title><![CDATA[BCL-2, BAX and P53 Expression Profiles in Endometrial Carcinoma as Studied by Real-time PCR and Immunohistochemistry]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2943853</link> 
<pubDate>11/10/2009</pubDate> 
<description><![CDATA[<b>Anticancer Research</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2943853</guid>
</item> 
 

<item> 
<title><![CDATA[Rapamycin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferation and induction of apoptosis]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2942265</link> 
<pubDate>11/10/2009</pubDate> 
<description><![CDATA[<b>International Journal of Cancer</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2942265</guid>
</item> 
 
 


  


</channel> 
</rss>

